Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Cogent Biosciences Inc (COGT)

Cogent Biosciences Inc (COGT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Cogent Biosciences Reports Recent Business Highlights and Third Quarter 2024 Financial Results GlobeNewswire - Tue Nov 12, 7:00AM CST

COGT : 8.98 (-1.10%)
Cogent Biosciences Announces Bezuclastinib Presentations at the 66th Annual American Society of Hematology (ASH) Meeting GlobeNewswire - Tue Nov 5, 8:00AM CST

COGT : 8.98 (-1.10%)
Cogent Biosciences Announces Pipeline Expansion into KRAS and Poster Presentations at the 2024 EORTC-NCI-AACR International Symposium on Molecular Targets and Cancer Therapeutics GlobeNewswire - Wed Oct 23, 6:00AM CDT

COGT : 8.98 (-1.10%)
Wall Street - Tall Buildings in New York City -J4M9FKPEaUA-unsplash
Markets Today: Stocks Slightly Higher on Strength in Tesla and Netflix Barchart - Wed Jun 7, 2023

Morning Markets June E-Mini S&P 500 futures (ESM2 3) this morning are up +0.09%, and June Nasdaq 100 E-Mini futures (NQM2 3) are up +0.11%. U.S. stock index futures this morning are slightly higher. Tesla...

ESZ24 : 5,974.00 (+0.06%)
NQZ24 : 20,831.75 (+0.01%)
TSLA : 339.64 (-0.70%)
NFLX : 897.48 (+1.54%)
PLAY : 34.10 (-0.44%)
AMZN : 198.38 (-2.22%)
YEXT : 7.95 (+2.58%)
SMCI : 29.70 (+15.12%)
NVCR : 17.09 (+1.36%)
CASY : 416.40 (+0.59%)
BASE : 21.02 (+3.09%)
UNFI : 23.61 (+3.37%)
Cogent Biosciences Reports Recent Business Highlights and Second Quarter 2022 Financial Results Globe Newswire - Tue Aug 9, 2022

On-track to present additional data from Phase 2 APEX trial by the end of 2022 Initial data from Phase 2 SUMMIT trial & lead-in data from Phase 3...

COGT : 8.98 (-1.10%)
Cogent Biosciences Announces Closing of Upsized Public Offering of Common Stock and Pre-funded Warrants and Full Exercise of Underwriters’ Option to Purchase Additional Shares Globe Newswire - Thu Jun 16, 2022

CAMBRIDGE, Mass. and BOULDER, Colo., June 16, 2022 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on...

COGT : 8.98 (-1.10%)
Cogent Biosciences Announces Pricing of Upsized Public Offering of Shares of Common Stock and Pre-funded Warrants Globe Newswire - Mon Jun 13, 2022

CAMBRIDGE, Mass. and BOULDER, Colo., June 13, 2022 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on...

COGT : 8.98 (-1.10%)
Cogent Biosciences Announces Proposed Public Offering of Common Stock Globe Newswire - Mon Jun 13, 2022

CAMBRIDGE, Mass. and BOULDER, Colo., June 13, 2022 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on...

COGT : 8.98 (-1.10%)
Cogent Biosciences Announces Positive Initial Clinical Data from Ongoing Phase 2 APEX Trial Evaluating Bezuclastinib in Patients with Advanced Systemic Mastocytosis (AdvSM) Globe Newswire - Fri Jun 10, 2022

All patients treated with bezuclastinib achieved ≥50% reduction in serum tryptase, with a median reduction of 89%, regardless of prior KIT D816V inhibitor...

COGT : 8.98 (-1.10%)
Cogent Biosciences to Host Investor Webcast on June 10, 2022 at 8:00am ET Globe Newswire - Mon Jun 6, 2022

– Event to review initial clinical data from APEX, a Phase 2 trial with bezuclastinib in Advanced Systemic Mastocytosis presented at European Hematology...

COGT : 8.98 (-1.10%)

Barchart Exclusives

1 AI Stock to Buy and Hold for Long-Term Growth Barchart - Thu Nov 21, 7:18PM CST
Pure Storage stands out in AI data storage, bolstered by a new partnership with CoreWeave and a solid financial track record, making it an intriguing stock for AI-focused investors Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot